Atıf Formatları
Irinotecan as a Second-line Monotherapy for Small Cell Lung Cancer
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

A. Sevinc Et Al. , "Irinotecan as a Second-line Monotherapy for Small Cell Lung Cancer," ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.12, pp.1055-1059, 2011

Sevinc, A. Et Al. 2011. Irinotecan as a Second-line Monotherapy for Small Cell Lung Cancer. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.12 , 1055-1059.

Sevinc, A., Kalender, M. E. , Altinbas, M., ÖZKAN, M., Dikilitas, M., & Camci, C., (2011). Irinotecan as a Second-line Monotherapy for Small Cell Lung Cancer. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.12, 1055-1059.

Sevinc, Alper Et Al. "Irinotecan as a Second-line Monotherapy for Small Cell Lung Cancer," ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.12, 1055-1059, 2011

Sevinc, Alper Et Al. "Irinotecan as a Second-line Monotherapy for Small Cell Lung Cancer." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.12, pp.1055-1059, 2011

Sevinc, A. Et Al. (2011) . "Irinotecan as a Second-line Monotherapy for Small Cell Lung Cancer." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.12, pp.1055-1059.

@article{article, author={Alper Sevinc Et Al. }, title={Irinotecan as a Second-line Monotherapy for Small Cell Lung Cancer}, journal={ASIAN PACIFIC JOURNAL OF CANCER PREVENTION}, year=2011, pages={1055-1059} }